Genetically-informed patient selection for iPSC studies of complex diseases may aid in reducing cellular heterogeneity

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)


Induced pluripotent stem cell (iPSC) technology is more and more used for the study of genetically complex human disease but is challenged by variability, sample size and polygenicity. We discuss studies involving iPSC-derived neurons from patients with Schizophrenia (SCZ), to exemplify that heterogeneity in sampling strategy complicate the detection of disease mechanisms. We offer a solution to controlling variability within and between iPSC studies by using specific patient selection strategies.

Original languageEnglish
Article number164
Pages (from-to)164
JournalFrontiers in cellular neuroscience
Publication statusPublished - 13 Jun 2017


  • Disease models
  • Genetics
  • IPSC
  • Journal Article
  • Psychiatric diseases
  • Schizophrenia
  • Statistical power
  • Stem cells
  • Variability

Cite this